サマリー

薬局自動化機器市場の成長とトレンド

Grand View Research, Inc.の新しいレポートによると、薬局自動化装置の世界市場規模は、2030年までに116億米ドルと予測され、予測期間中に9.8%のCAGRを記録しているとのことである。投薬コストやミスを削減し、薬局システムの効率を高める必要性が高まっていることが、市場成長の主要な推進要因となっています。これらのユニットの自動化は、業界全体の成長をもたらしただけでなく、処方薬の無駄を著しく減少させています。また、患者の満足度を向上させるだけでなく、薬剤師がより合理的な方法で業務を管理できるようになりました。経済先進国において、投薬ミスや薬の無駄は大きな問題です。

これらは薬物有害反応につながり、すでに増加している医療費に拍車をかけています。Integrated Pharmacy Research and Practice誌に掲載された論文によると、入院の6.5%は薬物有害反応によるものだそうです。WHOによると、これらのエラーは1日に少なくとも1人の死亡を引き起こし、米国では毎年100万人以上に深刻な被害を与えています。投薬ミスに関連する世界のコストは、年間420億米ドルと報告されています。欧州投資銀行が発表した記事によると、ギリシャでは毎年約10億ドル相当の医薬品が無駄に捨てられているとのことです。製品タイプ別では、投薬システム（MDS）が最も大きなシェアを占めています。

薬局がより正確に薬を調剤できるようになったことで、投薬ミスが減り、また在庫管理もしやすくなったため、薬局の運営コストがさらに削減されるようになりました。保健社会福祉省は、現在の処方箋量の10％が過剰処方薬であると推定しています。自動薬剤調合システムは、調合時のミスをなくし、汚染を軽減することができるため、今後数年間で最も急速に成長すると考えられます。最終用途別では、小売薬局向けが最も大きなシェアを占めています。過去数年間で、小売薬局や薬局チェーンの数は世界的に増加しています。OECDのデータによると、小売薬局の数は過去20年間増加し続けており、特にOECD加盟国（人口10万人あたり88店舗）で増加しています。

また、患者の転帰を改善するために投薬の不一致やミスを管理する必要性から病院薬局の分野も成長しており、業界全体の成長に影響を与えています。2021年の世界収益では、北米が最大のシェアを占めましたが、これは同地域の薬局チェーンや病院システムの多さだけでなく、強力な医療インフラに起因するものです。アジア太平洋地域で最も速い成長が見られたが、これは高齢者人口の増加、医療インフラの改善、医療費の増加などに起因する。無駄を省き、医薬品を適切に管理する必要性が高まっていることが、この地域の成長の主な要因となっています。

薬局自動化装置市場のレポートハイライト

- 2021年、薬剤調剤システム製品タイプセグメントが業界を席巻

- 2021年、小売薬局のエンドユーズセグメントが世界の業界を席巻

- この成長の背景には、小売薬局の増加やその管理ニーズの高まりがある

- 予測期間中、アジア太平洋地域が最も速いCAGRで成長すると予想される

- この成長は、同地域における患者数の増加と医療制度の改善に起因するものと思われます。

- COVID-19の大流行により、薬剤を必要とする患者の数が増加している

- スタッフの不足が業界の成長を可能にしました。これは、薬の需要の増加と薬局の適切な管理で業界が繁栄する機会を提供しました。

ページTOPに戻る

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Process
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 GVR’s internal database
1.3.2 Primary Research
1.4 Research Methodology
1.4.1 Approaches Implemented
1.4.2 Estimation & Forecast Of Year - On - Year Growth Rate
1.5 Region-based Segment Share Calculation
1.6 Research Scope and Assumptions
1.7 List of Secondary Sources
1.8 List of Primary Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Pharmacy Automation Devices Market Snapshot
Chapter 3 Pharmacy Automation Devices Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.1.2.1 Pharmacy inventory management
3.2 Penetration and Growth Prospect Mapping
3.3 Pharmacy Automation Devices Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Rise in Medication Errors
3.3.1.2 Surge In Adoption Of Pharmacy Automation Technology Owing To Its Advantages
3.3.1.3 Significant Need For Cutting Down Unnecessary Costs
3.3.1.4 Technological advancements
3.3.2 Market Restraint Analysis
3.3.2.1 Lack of skilled personnel in the automation sector
3.3.2.2 High cost of Pharmacy Automation Devices
3.3.3 Market Opportunities Analysis
3.3.3.1 Ongoing COVID-19 Pandemic is Increasing awareness regarding automation among pharmacists
3.3.4 Market Challenge Analysis
3.3.4.1 Stringency Of Regulatory Procedures
3.4 Pharmacy Automation Devices Industry Analysis - Porter’s Five Forces
3.4.1 Bargaining Power Of Suppliers -Moderate
3.4.2 Bargaining Power Of The Buyers - Low
3.4.3 Threat Of Substitution - Low
3.4.4 Threats Of New Entrants -Moderate
3.4.5 Competitive Rivalry - High
3.5 Pharmacy Automation Devices Industry Analysis - PEST
3.5.1 Political And Legal Landscape
3.5.2 Economic And Social Landscape
3.5.3 Environment And Technology Landscape
3.6 Major Deals & Strategic Alliances Analysis
3.6.1 Product Launches
3.6.2 Mergers & Acquisitions:
3.6.3 Partnerships And Collaborations
3.6.4 Investments And Agreements
3.6.5 Regulatory Approvals, Geographical Expansion, And Other Initiatives
3.7 Impact of COVID-19 on Pharmacy Automation Devices Market
Chapter 4 Pharmacy Automation Devices Market: Product Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 Pharmacy Automation Devices Market: Product Analysis, USD Million, 2021 & 2030
4.2.1 Medication Dispensing Systems
4.2.1.1 Medication dispensing systems market estimates and forecasts, 2016 - 2030 (USD Million)
4.2.2 Packaging And Labeling Systems
4.2.2.1 Packaging and labeling systems market estimates and forecasts, 2016 - 2030 (USD Million)
4.2.3 Storage And Retrieval Systems
4.2.3.1 Storage and retrieval systems market estimates and forecasts, 2016 - 2030 (USD Million)
4.2.4 Automated Medication Compounding Systems
4.2.4.1 Automated medication compounding systems market estimates and forecasts, 2016 - 2030 (USD Million)
4.2.5 Tabletop Tablet Counters
4.2.5.1 Tabletop Tablet Counters market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 5 Pharmacy Automation Devices Market: End-use Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 Pharmacy Automation Devices Market: End-use Analysis, USD Million, 2021 & 2030
5.2.1 Hospital Pharmacy
5.2.1.1 Hospital Pharmacy market estimates and forecasts, 2016 - 2030 (USD Million)
5.2.2. Retail Pharmacy
5.2.2.1 Retail Pharmacy market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 6 Pharmacy Automation Devices Market: Regional Estimates & Trend Analysis: By Product and End Use
6.1 Regional Market Snapshot
6.2 Pharmacy Automation Devices Market Movement Analysis, By Region, 2021 & 2030, USD Million
6.3 North America
6.3.1 North America Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.3.3 Canada
6.3.3.1 Canada Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4 Europe
6.4.1 Europe Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.2 Germany
6.4.2.1 Germany Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.3 U.K.
6.4.3.1 U.K. Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.4 France
6.4.4.1 France Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.5 Italy
6.4.5.1 Italy Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.6 Spain
6.4.6.1 Spain Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.7 Russia
6.4.7.1 Russia Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5 APAC
6.5.1 APAC Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.2 China
6.5.2.1 China Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.3 India
6.5.3.1 India Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.4 Japan
6.5.4.1 Japan Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.5 Australia
6.5.5.1 Australia Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.6 Singapore
6.5.6.1 Singapore Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.7 South Korea
6.5.7.1 South Korea Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6 Latin America
6.6.1 Latin America Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.3 Mexico
6.6.3.1 Mexico Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.4 Argentina
6.6.4.1 Argentina Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7 MEA
6.7.1 MEA Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.3 Saudi Arabia
6.7.3.1 Saudi Arabia Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.4 UAE
6.7.4.1 UAE Pharmacy Automation Devices Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.1.1 Joint Venture
7.1.1.1 Dosis joint venture with 2KM
7.1.2 Mergers & Acquisitions
7.1.2.1 AmerisourceBergen and Walgreens Boots enter into a strategic alliance With Walgreens Boots Alliance
7.1.2.2 Becton, Dickinson and Company (BD) acquired CUBEX LLC
7.1.2.3 Auxo Investment Partner acquired Euclid Medical Products
7.1.2.4 Capsa Healthcare acquired RoboPharma
7.1.2.5 Richards Packaging acquired Clarion Medical Technologies
7.1.2.6 MedAvail merged with MYOS RENS Technology
7.1.2.7 Noritsu acquired R&F Imaging, Inc.
7.1.2.8 Francisco Partners acquired Smith Technologies
7.1.2.9 TouchPoint Medical acquired Health Tech
7.1.2.10 TCGRx merged with Parata Systems
7.1.2.11 TCGRx acquired ARxIUM’s Panasonic products
7.1.2.12 Swisslog Healthcare acquired Talyst
7.1.2.13 Frazier Healthcare Partners acquired TCGRx
7.1.2.14 Capsa Healthcare acquired Kirby Lester
7.1.2.15 Omnicell acquired MACH4 Pharma Systems
7.1.2.16 Omnicell acquired InPharmics
7.1.2.17 TCGRx acquired Integrated Automation Solutions (IAS)
7.1.2.18 Omnicell acquired Ateb
7.1.2.19 Swisslog Healthcare acquired Tecnilab
7.1.2.20 Swisslog Warehouse and Distribution Solutions acquired Power Automation Systems
7.1.2.21 PharmCo acquired Script Pro LLC
7.1.2.22 Omnicell acquired Aesynt, Inc.
7.1.2.23 Richards Packaging acquired Healthmark
7.1.2.24 Becton, Dickinson and Company (BD) acquired CareFusion Corporation
7.1.2.25 Intelligent Hospital Systems acquired AutoMed Technologies
7.1.3 Partnerships
7.1.3.1 Cerner Corporation partnered with Xealth
7.1.3.2 Synergy Medical partnered with MED-ID
7.1.3.3 Synergy Medical partnered with MedEye
7.1.3.4 Cerner Corporation partnered with ResMed
7.1.3.5 Swisslog Healthcare partnered with Pharmony
7.1.3.6 Omnicell partnered with Inova
7.1.3.7 Swisslog Healthcare partnered with Telecar
7.1.3.8 Talyst partnered with McFarlane Medical
7.1.4 Distribution Agreements
7.1.4.1 iA and Becton, Dickinson and Company
7.1.4.2 AmerisourceBergen and U.S. CDC
7.1.4.3 Deenova SRL and PharmaTech Medical Equipment
7.1.4.4 NewIcon and Al-Razi Pharmacy Company
7.1.4.5 PerceptiMed and Smith Drug Company
7.1.5 Collaborations
7.1.5.1 MedAvail and Kitron
7.1.5.2 Cerner Corporation and DrFirst
7.1.5.3 Becton, Dickinson and Company (BD) and Helmer Scientific
7.1.5.4 McKesson and Discount Drug Market
7.1.6 Product Launches
7.1.6.1 Omnicell launched EnlivenHealth
7.1.6.2 Capsa Healthcare launched Trio
7.1.6.3 Swisslog Healthcare launched Meds-to-Beds program
7.1.6.4 Medacist launched RxAuditor Investigate
7.1.6.5 TouchPoint Medical launched TouchPoint Medical Financial Solutions
7.1.6.6 AmerisourceBergen launched new tools for pharmacies
7.1.6.7 Baxter International received regulatory approval for Evo IQ Infusion System
7.1.6.8 Baxter International received FDA approval for Spectrum IQ and Dose IQ Infusion System
7.1.6.9 Medacist launched RxAuditor Investigate
7.1.6.10 Becton, Dickinson and Company (BD) launched BD HealthSight
7.1.6.11 McKesson launched Central Fill
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 Key Company Market Share Analysis, 2021
7.4 Public Companies
7.4.1 Company Market Position Analysis
7.4.2 Competitive Dashboard Analysis
7.5 Private Companies
7.5.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
7.5.2 Company Market Position Analysis
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Amerisouce Bergen Corporation
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Accu-Chart Plus Healthcare Systems, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 product benchmarking
8.1.3 Omnicell, Inc.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 McKesson Corporation
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Pearson Medical Technologies
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 product benchmarking
8.1.6 Baxter
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Talyst, LLC
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 ScriptPro, LLC
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 CareFusion (Becton Dickinson and Company)
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Fulcrum Pharmacy Management, Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 product benchmarking
8.1.11 Health Robotics S.R.L.
8.1.11.1 Company overview
8.1.12 Medacist Solutions Group, LLC
8.1.12.1 Company overview
8.1.12.2 Financial performance
8.1.12.3 product benchmarking
8.1.12.4 Strategic initiatives
8.1.13 Aesynt, Inc.
8.1.13.1 Company overview
8.1.14 Pyxis Corporation
8.1.14.1 Company overview
8.1.15 Kirby Lester (Acquired By Capsa Healthcare)
8.1.15.1 Company overview
8.1.15.2 Financial performance
8.1.15.3 product benchmarking
8.1.15.4 Strategic initiatives
8.1.16 Cerner Corporation
8.1.16.1 Company overview
8.1.16.2 Financial performance
8.1.16.3 product benchmarking
8.1.16.4 Strategic initiatives
8.1.17 Forhealth Technologies
8.1.17.1 Company overview
8.1.18 iA
8.1.18.1 Company overview
8.1.18.2 Financial performance
8.1.18.3 product benchmarking
8.1.18.4 Strategic initiatives
8.1.19 ARxIUM
8.1.19.1 Company overview
8.1.19.2 Financial performance
8.1.19.3 product benchmarking
8.1.19.4 Strategic initiatives
8.1.20 Touchpoint Medical
8.1.20.1 Company overview
8.1.20.2 Financial performance
8.1.20.3 product benchmarking
8.1.20.4 Strategic initiatives
8.1.21 Deenova S.R.L
8.1.21.1 Company overview
8.1.21.2 Financial performance
8.1.21.3 product benchmarking
8.1.21.4 Strategic initiatives
8.1.22 Parata Systems, LLC
8.1.22.1 Company overview
8.1.22.2 Financial performance
8.1.22.3 product benchmarking
8.1.22.4 Strategic initiatives
8.1.23 Swisslog Healthcare
8.1.23.1 Company overview
8.1.23.2 Financial performance
8.1.23.3 product benchmarking
8.1.23.4 Strategic initiatives
8.1.24 Yuyama Co. Ltd./Yuyama Mfg Co. Ltd.
8.1.24.1 Company overview
8.1.24.2 Financial performance
8.1.24.3 product benchmarking
8.1.24.4 Strategic initiatives